Trichloroethanol enhances the activity of recombinant human TREK-1 and TRAAK channels

Neuropharmacology

Volumn 46, Issue 5, 2004, Pages 750-760

  Harinath, S ^a   Sikdar, S K ^a  

^a INDIAN INSTITUTE OF SCIENCE   (India)

Author keywords

2P domain, two pore domain; Anesthetic; CH, Chloral hydrate; Chloral hydrate; CHO, Chinese hamster ovary cells; TCE, 2,2,2 Trichloroethanol; TFE, 2,2,2 Trifluoroethanol; TRAAK channel; TREK 1 channel; Trichloroethanol; Whole cell patch clamp recording

Indexed keywords

ANESTHETIC AGENT; CHLORAL HYDRATE; MEMBRANE PROTEIN; POTASSIUM CHANNEL; PROTEIN TRAAK; PROTEIN TREK 1; RECOMBINANT PROTEIN; TRICHLOROETHANOL; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CARBOXY TERMINAL SEQUENCE; CENTRAL NERVOUS SYSTEM DEPRESSION; CHO CELL; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG POTENTIATION; DRUG SENSITIVITY; FEMALE; MEMBRANE CHANNEL; METABOLITE; MODULATION; NONHUMAN; NUCLEOTIDE SEQUENCE; PATCH CLAMP; PRIORITY JOURNAL; RECORDING; SYNAPTIC INHIBITION; SYNAPTIC POTENTIAL; TIME;

ANIMALS; CHO CELLS; CRICETINAE; DOSE-RESPONSE RELATIONSHIP, DRUG; ETHYLENE CHLOROHYDRIN; HUMANS; MEMBRANE POTENTIALS; POTASSIUM CHANNELS; POTASSIUM CHANNELS, TANDEM PORE DOMAIN; RATS; RECOMBINANT PROTEINS;

EID: 1442299852     PISSN: 00283908     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuropharm.2003.11.023     Document Type: Article

References (31)

1. Breimer D.D. Clinical pharmacokinetics of hypnotics. Clinical Pharmacokinetics. 2:1977;93-109.
2. + channels TREK-1 and TRAAK. Molecular Pharmacology. 57:2000;906-912.
3. Eftink M.R., Zajicek J.L., Ghiron C.A. A hydrophobic quencher of protein fluorescence: 2,2,2-trichloroethanol. Biochimica et Biophysica Acta. 491:1977;473-481.
4. + channel stimulated by arachidonic acid and polyunsaturated fatty acids. The EMBO Journal. 17:1998;3297-3308.
5. 2+ influx in rat cultured cortical neurones. European Journal of Pharmacology. 394:2000;41-45.
6. Franks N.P., Lieb W.R. Molecular and cellular mechanisms of general anaesthesia. Nature. 367:1994;607-614.
7. A receptor activity by α-chloralose. Journal of Pharmacology and Experimental Therapeutics. 285:1998;680-686.
8. Goldstein S.A.N., Price L.A., Rosenthal D.N., Pausch M.H. ORK1, a potassium selective leak channel with two pore domains cloned from Drosophila melanogaster by expression in Saccharomyces cerevisiae. Proceedings of the National Academy of Sciences of the United States of America. 93:1996;13256-13261.
9. Hervieu G.J., Cluderay J.E., Gray C.W., Green P.J., Ranson J.L., Randall A.D., Meadows H.J. Distribution and expression of TREK-1, a two-pore-domain potassium channel, in the adult rat CNS. Neuroscience. 103:2001;899-919.
10. Hobbs W.R., Rall T.W., Verdoorn T.A. Hypnotics and sedatives: ethanol. Hardman J.G., Limbird L.E., Molinoff P.B., Ruddon R.W., Gilman A.G. The Pharmacological Basis of Therapeutics. 1996;361-396 McGraw-Hill, New York.
11. ρ1 receptors. Journal of Pharmacology and Experimental Therapeutics. 284:1998;934-942.
12. + channel with a novel structure. The EMBO Journal. 15:1996;1004-1011.
13. + channel. FEBS Letters. 471:2000;137-140.
14. Lopes C.M.B., Gallagher P.G., Buck M.E., Butler M.H., Goldstein S.A.N. Proton block and voltage gating are potassium-dependent in the cardiac leak channel Kcnk3. Journal of Biological Chemistry. 275:2000;16969-16978.
15. A receptors in hippocampal neurons. Journal of Pharmacology and Experimental Therapeutics. 264:1993;1097-1103.
16. + channel. Journal of Biological Chemistry. 274:1999a;1381-1387.
17. Maingret F., Patel A.J., Lesage F., Lazdunski M., Honore E. Mechano- or acid stimulation, two interactive modes of activation of the TREK-1 potassium channel. Journal of Biological Chemistry. 274:1999b;26691-26696.
18. + channel. Biochemical and Biophysical Research Communications. 292:2002;339-346.
19. + channels in central neuroprotection. Journal of Physiology. 548:2003a;31-37.
20. Miller, P., Peers, C., Kemp, P.J., 2003b. Polymodal regulation of hTREK-1 by pH, arachidonic acid and hypoxia: physiological impact in acidosis and alkalosis. American Journal of Physiology Cell Physiology (in press).
21. Owen B.E., Taberner P.V. Studies on the hypnotic effects of chloral hydrate and ethanol and their metabolism in vivo and in vitro. Biochemical Pharmacology. 29:1980;3011-3016.
22. + channel. The EMBO Journal. 17:1998;4283-4290.
23. + channels. Nature Neuroscience. 2:1999;422-426.
24. Peoples R.W., Weight F.F. Trichloroethanol potentiation of γ-aminobutyric acid-activated chloride current in mouse hippocampal neurones. British Journal of Pharmacology. 113:1994;555-563.
25. Peoples R.W., Weight F.F. Inhibition of excitatory aminoacid-activated currents by trichloroethanol and trifluoroethanol in mouse hippocampal neurones. British Journal of Pharmacology. 124:1998;1159-1164.
26. Powell T.G., Rosenbloom L. The use of chloral hydrate for refractory childhood epilepsy. Developmental Medicine and Child Neurology. 25:1983;524-526.
27. Pranzatelli P.R., Tate E.D. Chloral hydrate for progressive myoclonus epilepsy: a new look at an old drug. Pediatric Neurology. 25:2001;385-389.
28. Pringle M.J., Brown K.B., Miller K.W. Can the lipid theories of anesthesia account for the cutoff in anesthetic potency of homologous series of alcohols? Molecular Pharmacology. 19:1981;49-55.
29. Reyes R., Lauritzen I., Lesage F., Ettaiche M., Fosset M., Lazdunski M. Immunolocalization of the arachidonic acid and mechanosensitive baseline traak potassium channel in the nervous system. Neuroscience. 95:2000;893-901.
30. Scheibler P., Kronfeld A., Illes P., Allgaier C. Trichloroethanol impairs NMDA receptor function in rat mesencephalic and cortical neurones. European Journal of Pharmacology. 366:1999;R1-R2.
31. Solt K., Johansson J.S. Binding of the active metabolite of chloral hydrate, 2,2,2-trichloroethanol, to serum albumin demonstrated using tryptophan fluorescence quenching. Pharmacology. 64:2002;152-159.